Sana Biotechnology
Latest round
- Series B
Last raised
- Feb 2019
Total raised
- $867M
Investors
- 11
About Sana Biotechnology
Founded in 2018 and based in the US, Sana Biotechnology, Inc. is a biotechnological company that develops engineered cells as medicines and therapies to treat diseases. The firm has 3 ways to treat a patient with untreated diseases. First, repair and control genes in any cell. Second, Replace any cell in the body. Third, Tear down barriers to accessing the therapies.
Who invested in Sana Biotechnology
11 investors across 2 rounds
See all investors in Sana Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sana Biotechnology
Who invested in Sana Biotechnology?
Sana Biotechnology has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sana Biotechnology raised?
Sana Biotechnology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Sana Biotechnology last raise money?
Sana Biotechnology's most recent round on record is a Series B, in Feb 2019.
What does Sana Biotechnology do?
Founded in 2018 and based in the US, Sana Biotechnology, Inc.
Where is Sana Biotechnology headquartered?
Sana Biotechnology is headquartered in Seattle, US.
Which VCs invest in companies like Sana Biotechnology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Sana Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Sana Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.